Quarterly report [Sections 13 or 15(d)]

Discontinued Operations - Schedule of Reconciliation of Discontinued Operations (Details)

v3.25.3
Discontinued Operations - Schedule of Reconciliation of Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Income (loss) from discontinued operations $ 0 $ (1,622) $ 8,644 $ (3,053)
Discontinued Operations, Disposed of by Sale | Pharmaloz        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenues, net 0 1,730 0 3,978
Cost of revenues 0 2,110 0 5,052
Gross loss 0 (380) 0 (1,074)
Operating expenses:        
General and administration 0 1,077 102 1,649
Research and development 0 0 0 0
Total operating expenses 0 1,077 102 1,649
Loss from operations 0 (1,457) (102) (2,723)
Interest expense 0 (165) 0 (360)
Other income 0 0 0 30
Income (loss) from discontinued operations $ 0 $ (1,622) $ (102) $ (3,053)